Seon Hui Balistrere
Adult Health · Hopkinsville, KYNPI 1033826946
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,420 of the $8,366 with a category attached, or 88.7%. It is spread thinly across 37 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,426, more than ten times the $97 reported in 2022. Among adult health clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 328 payments — averaging $25.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- AstraZeneca$1K
- GSK$1K
- Jazz Pharmaceuticals Inc.$504
- Regeneron Healthcare Solutions, Inc.$421
- Sanofi$357
- plus $4K from 31 others
What the payments were for
- Travel & lodging$7529%
- Food & beverage$7,42089%
- Education$1932%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 14 | $1,210 |
| AstraZeneca | 38 | $1,170 |
| GSK | 59 | $1,047 |
| Jazz Pharmaceuticals Inc. | 15 | $504 |
| Regeneron Healthcare Solutions, Inc. | 22 | $421 |
| Sanofi | 19 | $357 |
| Harmony Biosciences LLC | 13 | $355 |
| Lilly USA, LLC | 8 | $324 |
| Avadel CNS Pharmaceuticals, LLC | 15 | $320 |
| Sumitomo Pharma America, Inc. | 8 | $243 |
| Gilead | 12 | $231 |
| Insmed, Inc. | 13 | $221 |
| Grifols USA, LLC | 15 | $215 |
| Boehringer Ingelheim | 12 | $211 |
| Verona Pharma, Inc. | 11 | $161 |
| Pulmonx Corporation | 3 | $153 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Novo Nordisk | 1 | $118 |
| Electromed, Inc. | 9 | $110 |
| United Therapeutics Corporation | 4 | $91 |
| Pfizer | 5 | $88 |
| AbbVie | 1 | $70 |
| Astellas Pharma US Inc | 2 | $69 |
| Novartis | 4 | $69 |
| Mallinckrodt Hospital Products Inc. | 3 | $66 |
| Idorsia Pharmaceuticals US Inc | 1 | $61 |
| Philips North America LLC | 4 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Lundbeck LLC | 3 | $50 |
| Amgen | 1 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Bayer | 2 | $30 |
| Merck | 1 | $24 |
| Johnson & Johnson | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $18 |
| Neurelis, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$698
- MOUNJARO$247
- FARXIGA$127
- GEMTESA$125
- NUZYRA$125
- CHARTIS CATHETER$123
- ZEPHYR DELIVERY CATHETER$123
- ZEPHYR ENDOBRONCHIAL VALVE$123
- PULMONX CHARTIS TABLET CONSOLE$123
- Wegovy$118
How this compares
$8,366 in reported general payments places this provider in the 95th percentile of 170 adult health providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $42,969 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 32 | $35,037 |
| TrulicityDulaglutide | 12 | $12,915 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $1,837 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 47 | $1,441 |
| Fluticasone Propionate | 30 | $278 |
| Atorvastatin Calcium | 42 | $256 |
| Montelukast Sodium | 24 | $250 |
| Levothyroxine Sodium | 26 | $230 |
| Azithromycin | 32 | $228 |
| Ropinirole Hcl | 36 | $176 |
| Gabapentin | 19 | $130 |
| Escitalopram Oxalate | 13 | $125 |
| Lisinopril | 13 | $82 |
| Simvastatin | 12 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $1,047 | $42,96954 claims |
| AstraZenecaBreztri Aerosphere | $1,170 | $35,03732 claims |
| Lilly USA, LLCTrulicity | $324 | $12,91512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 170 adult health providers in Kentucky.
Other adult health in Hopkinsville
- Carrie Clifford-BennettGeorgetown$730K
- Stephanie FlaspoehlerLouisville$174K
- Kimberly VesselsBrandenburg$58K
- Heidi GalloLouisville$15K
- Amy BakerPaducah$14K
- Joyce JohnsonElizabethtown$12K
- Karen EastridgeLouisville$10K
- Barbara CarpenterLouisville$8K
- Jennifer ThomasPaducah$7K
- Deborah WelshPaducah$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.